---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-006628"
form_type: "8-K"
ticker: "TCMD"
cik: "0001027838"
company_name: "TACTILE SYSTEMS TECHNOLOGY INC"
filed_at: "2022-05-02T23:59:59+00:00"
generated_at: "2026-06-26T01:52:20.242380+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Tactile Medical Q1 revenue $48.0M (+12% YoY); net loss $15.6M vs $2.3M loss YoY

## Summary
- Revenue $48.0M (+12% YoY); net loss $15.6M ($0.78 diluted EPS) vs $2.3M ($0.12) in Q1 2021.
- Operating loss $14.9M vs $4.1M YoY; non-GAAP operating loss $5.4M vs $3.1M.
- Adjusted EBITDA loss $2.6M vs $7K loss YoY.
- Reaffirmed FY2022 revenue guidance $235M-$240M (13-15% growth).
- Airway clearance product line contributed $7.3M revenue; lymphedema product line declined 5%.

## SEC filing metadata
- accession: 0001558370-22-006628
- form_type: 8-K
- ticker: TCMD
- cik: 0001027838
- company_name: TACTILE SYSTEMS TECHNOLOGY INC
- filed_at: 2022-05-02T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1027838/000155837022006628/0001558370-22-006628-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1027838/000155837022006628/tcmd-20220502x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-006628
- JSON: https://secwatch.observer/filing/0001558370-22-006628.json
- Plain text: https://secwatch.observer/filing/0001558370-22-006628.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.